Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T01:59:22.744Z Has data issue: false hasContentIssue false

Hospital-Based Pneumococcal Immunization: The Epidemiologic Rationale and Its Implementation

Published online by Cambridge University Press:  02 January 2015

David S. Fedson*
Affiliation:
Department of Medicine, The University of Chicago, Chicago, Illinois
*
Department of Medicine, The University of Chicago, 950 East 59th Street, Chicago, IL 60637

Abstract

Many patients hospitalized for or dying of pneumococcal bacteremia have been discharged from a hospital with in the previous five years. In addition to age and underlying medical condition, previous hospital care, particularly for high risk conditions, is a useful marker for identifying individuals who are destined to develop serious pneumococcal infections. Relatively few patients, especially those with high risk conditions, would need to receive pneumococcal vaccine at the time of hospital discharge to prevent, within the next five years, each subsequent readmission or death from pneumococcal pneumonia. Although pneumococcal vaccine has not been widely used in the hospital setting, there are sound epidemiologic reasons to expect that organized programs for vaccine delivery in hospitals would be an effective approach to preventing many serious pneumococcal infections.

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1982

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable